What to Watch in 2021 - Big Changes for Drug Companies in China
By EsqSocial Corporation 22/12/20
For several years, China has been evaluating changes to its drug approval system to promote drug innovation and patient access to medicines. The year 2020 saw China begin taking steps towards adopting some of those changes. U.S. biopharma companies doing business in China, and those looking to do business in China, should start preparing now for the changes coming in 2021....
By: Kilpatrick Townsend & Stockton LLP